MP
GSK icon

McDonald Partners’s GSK GSK Stock Holding History

McDonald Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,918
Closed -$213K – 241
2022
Q2 		$213K Buy
3,918
+1
+0% +$55 0.05% 274
2022
Q1 		$213K Buy
+3,917
New +$213K 0.05% 289
2021
Q4 		– Sell
-6,482
Closed -$310K – 616
2021
Q3 		$310K Buy
6,482
+1,122
+21% +$56.4K 0.07% 245
2021
Q2 		$267K Buy
5,360
+402
+8% +$19.3K 0.06% 258
2021
Q1 		$221K Buy
4,958
+1
+0% +$45 0.06% 267
2020
Q4 		$228K Buy
+4,957
New +$228K 0.06% 252

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

McDonald Partners's GSK Position: Q3 2022 in Review

McDonald Partners sold out of GSK (GSK) in Q3 2022, closing a stake of 3,918 shares — an estimated $213K sold.

McDonald Partners first reported a position in GSK in Q4 2020 and held it in 6 quarters. The position peaked at $310K in Q3 2021. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • McDonald Partners reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
  • McDonald Partners sold 3,918 GSK shares in Q3 2022, an estimated $213K.
  • McDonald Partners first reported a position in GSK in Q4 2020 and held it in 6 quarters.
  • McDonald Partners's GSK position peaked at $310K in Q3 2021.
  • 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on McDonald Partners's 13F filing for Q3 2022, filed 21 Oct 2022.